Literature DB >> 1491360

A summary of attentional findings in the New York High-Risk Project.

L Erlenmeyer-Kimling1, B A Cornblatt.   

Abstract

We summarize here our findings with respect to attentional impairment among offspring of schizophrenic, affectively ill, and normal parents followed from childhood to adulthood during the two decades of the New York High-Risk Project (NYHRP). We review our data first, on childhood attentional performance in each of our two independent samples of such subjects and, second, on the relationship of early dysfunctions observed in this domain to psychopathological outcomes in adolescence and adulthood. Our cumulative results contribute strong support to the contention that global attentional dysfunctions may be viewed as a biobehavioral marker for the genetic liability to schizophrenic disorders.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1491360     DOI: 10.1016/0022-3956(92)90043-n

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  18 in total

Review 1.  The NEWMEDS rodent touchscreen test battery for cognition relevant to schizophrenia.

Authors:  M Hvoslef-Eide; A C Mar; S R O Nilsson; J Alsiö; C J Heath; L M Saksida; T W Robbins; T J Bussey
Journal:  Psychopharmacology (Berl)       Date:  2015-07-24       Impact factor: 4.530

2.  Poor school performance in offspring of patients with schizophrenia: what are the mechanisms?

Authors:  J Jundong; R Kuja-Halkola; C Hultman; N Långström; B M D'Onofrio; Paul Lichtenstein
Journal:  Psychol Med       Date:  2011-07-07       Impact factor: 7.723

Review 3.  Neurocognition in youth and young adults under age 30 at familial risk for schizophrenia: a quantitative and qualitative review.

Authors:  Jessica Agnew-Blais; Larry J Seidman
Journal:  Cogn Neuropsychiatry       Date:  2012-09-21       Impact factor: 1.871

4.  Neuropsychological functioning in adolescents and young adults at genetic risk for schizophrenia and affective psychoses: results from the Harvard and Hillside Adolescent High Risk Studies.

Authors:  Larry J Seidman; Anthony J Giuliano; Christopher W Smith; William S Stone; Stephen J Glatt; Eric Meyer; Stephen V Faraone; Ming T Tsuang; Barbara Cornblatt
Journal:  Schizophr Bull       Date:  2006-05-17       Impact factor: 9.306

5.  Cognition in Friedreich ataxia.

Authors:  Antonieta Nieto; Rut Correia; Erika de Nóbrega; Fernando Montón; Stephany Hess; Jose Barroso
Journal:  Cerebellum       Date:  2012-12       Impact factor: 3.847

6.  Executive dysfunction in Turkish children at high risk for schizophrenia.

Authors:  Nese Perdahli Fis; Fusun Cuhadaroglu Cetin; Mihriban Erturk; Emel Erdogan; Ceyda Dedeoglu; Yanki Yazgan
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-04-21       Impact factor: 4.785

7.  The New York High-Risk Project. Psychoses and cluster A personality disorders in offspring of schizophrenic parents at 23 years of follow-up.

Authors:  L Erlenmeyer-Kimling; E Squires-Wheeler; U H Adamo; A S Bassett; B A Cornblatt; C J Kestenbaum; D Rock; S A Roberts; I I Gottesman
Journal:  Arch Gen Psychiatry       Date:  1995-10

8.  Cognition in late-onset Friedreich ataxia.

Authors:  Antonieta Nieto; Rut Correia; Erika de Nóbrega; Fernando Montón; Jose Barroso
Journal:  Cerebellum       Date:  2013-08       Impact factor: 3.847

9.  Auditory working memory impairments in individuals at familial high risk for schizophrenia.

Authors:  Larry J Seidman; Eric C Meyer; Anthony J Giuliano; Hans C Breiter; Jill M Goldstein; William S Kremen; Heidi W Thermenos; Rosemary Toomey; William S Stone; Ming T Tsuang; Stephen V Faraone
Journal:  Neuropsychology       Date:  2012-05       Impact factor: 3.295

10.  Altered functional connectivity strength and its correlations with cognitive function in subjects with ultra-high risk for psychosis at rest.

Authors:  Ran-Ran Li; Hai-Long Lyu; Feng Liu; Nan Lian; Ren-Rong Wu; Jing-Ping Zhao; Wen-Bin Guo
Journal:  CNS Neurosci Ther       Date:  2018-04-24       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.